MMT-17543-66945
3 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Moderna
-
2020-12-30
Registered in v-safe
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-11
- 2021-01-18
-
2021-01-25
Dose 2 — Moderna
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Foetal hypokinesia, Pyrexia — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Decreased fetal movement while febrileMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-03
-
2021-02-08
Survey response — day 14, dose 2MedDRA: Dizziness, Vertigo — Feeling: GoodFree text: Some dizziness/vertigo about 11-13 days after second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-04-26
-
2021-04-30
Call successfulDoes not wish to fill out VAERS report
- 2021-07-26
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2022-01-25
- 2022-06-03
-
2022-12-03
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Currently have a coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Decreased fetal movement while febrile
Release 3 — day 14, dose 2
Symptoms: Some dizziness/vertigo about 11-13 days after second dose
Release 12 — 12 months, dose 3
Symptoms: Currently have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Foetal hypokinesia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release